The Regulator
CMS’s proposed CRUSH fraud rule would make every provider billing Medicare Advantage enroll in Original Medicare, and the agency says it could save nearly $90 billion over 10 years. The Centers for Medicare & Medicaid Services (CMS) issued “Comprehensive Regulations To Uncover Suspicious Healthcare” (CRUSH, CMS-6098-P) November 16, and it was published in the Federal Register November 19 at 91 FR 74680. It covers Medicare, Medicaid, the Children’s Health Insurance Program and the Marketplace. Providers and suppliers would have to report any enrollment change within 30 days; today only critical changes carry a 30-day clock and others get up to 90. Anyone billing a Medicare Advantage plan would have to be enrolled in Original Medicare, with its site visits and fingerprint checks, starting the first plan year two years after a final rule. States would face CMS-run Medicaid eligibility audits at least once every five years, with federal funding disallowed when a state’s error rate tops 3 percent. For Medicare Advantage plans, the proposal would drop the fee-for-service adjuster in risk adjustment audits and extrapolate findings starting with payment year 2018 audits. CMS’s fact sheet puts the cost at about $378.51 million from 2027 to 2036 against nearly $90 billion in federal savings, and the Federal Register text says the Office of the Actuary has not scored the rule. Who it hits: home health and personal care providers, medical equipment suppliers, Medicare Advantage plans, state Medicaid agencies and Marketplace brokers. Comments are due January 19, 2027 at regulations.gov docket CMS-2026-0826. Confidence: High on the dates and the dollar claims as CMS states them; Med on provision details, because we read the fact sheet and only the first part of the 1.2-million-character rule text; Low on whether the savings are achievable. Sources: Federal Register, CRUSH proposed rule (2026-23461), CMS fact sheet, CMS-6098-P, CMS press release.
UPDATE on the Capricor Duchenne heart therapy we covered August 21: the Food and Drug Administration (FDA) refused approval Friday night. Capricor Therapeutics, a cell-therapy company, said in a November 20 press release that the FDA issued a Complete Response Letter on deramiocel, its treatment for the heart damage caused by Duchenne muscular dystrophy. The company says the letter states the agency “does not consider the data sufficient to establish substantial evidence of effectiveness” and cites “certain other clinical deficiencies.” Capricor held about $198.5 million in cash and securities on September 30 and says that funds operations for at least 12 months while it reviews costs. It has a call at 8:30 a.m. Eastern Monday to discuss next steps. Who it hits: Duchenne families waiting on a first cardiac therapy, and investors in the company. Confidence: High that the letter issued, as the company states it; Med on its contents, since we found no FDA statement and have not seen the letter. Sources: Capricor press release.
States will see their Medicaid federal match rates for fiscal 2028 in Monday’s Federal Register: 10 states sit at the 50 percent floor, and Puerto Rico drops from 76 percent to 55 percent. The Department of Health and Human Services (HHS) notice sets the Federal Medical Assistance Percentage (FMAP), the share of Medicaid costs Washington pays, for October 1, 2027 through September 30, 2028. California, Colorado, Connecticut, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Washington and Wyoming are at the 50 percent minimum. Mississippi is highest among the states at 77.62 percent, followed by West Virginia at 74.67 percent and Alabama at 72.81 percent. Puerto Rico’s 76 percent rate runs only through September 30, 2027 and reverts to 55 percent after, which the notice ties to section 1905(b)(2) of the Social Security Act. The notice gives no comparison with the current year, so we cannot say how many states gain or lose. Who it hits: state budget offices and the hospitals and health plans in Puerto Rico that depend on the higher match. Confidence: High on the states and rates named, which we read from the filed text; Med on the rest of the table, which we did not verify state by state. Sources: Federal Register public inspection, FMAP notice (2026-23741).
UPDATE on the Medicare Advantage proposal we covered Friday: the 868-page rule publishes in the Federal Register Wednesday, and its text sets the comment clock from the filing date. The Contract Year 2028 proposed rule, CMS-4214-P2, was filed for public inspection November 20 and is scheduled for publication November 25 under docket CMS-2026-3533. Its comment instruction reads “60 days after date of filing for public inspection,” which works out to January 19, 2027. That differs from the 60 days after publication that CMS’s press materials describe, so the January 19 date is our calculation, not a printed date. The rule includes the mandatory ADVaNCE MA model. Who it hits: Medicare Advantage and Part D plans, and Programs of All-Inclusive Care for the Elderly (PACE) operators, which the rule’s title also names. Confidence: High on the filing, publication date and docket; Med on the deadline until the published version prints it. Sources: Federal Register public inspection, CMS-4214-P2 (2026-23960), CMS press release.
UPDATE on the measles status story we covered November 16: the Centers for Disease Control and Prevention (CDC) counts 5,838 confirmed U.S. cases in 2026 and says the country lost elimination status this year. As of noon November 19, 47 jurisdictions had reported 5,820 cases, plus 18 among international visitors. CDC lists 43 new outbreaks in 2026, with 96 percent of cases tied to an outbreak. For comparison, 2025 had 2,289 cases and 48 outbreaks. CDC’s page says sustained spread of at least 12 months led to the loss of elimination status, without a date, and it does not mention the Pan American Health Organization (PAHO); we did not find a PAHO statement this run. Who it hits: pediatric and primary care practices, school districts and state health departments running outbreak response. Confidence: High on the case counts; Med on the status wording, which comes from one page with no date. Sources: CDC measles data page.
Quiet note: the Office of Inspector General enforcement feed lists nothing dated after November 19, and Sunday carries no Federal Register issue. Monday’s issue also brings two NIOSH notices on workplace robots and a carbon monoxide exposure limit, both with comments due February 22, 2027. We found no verified court ruling dated in the last 48 hours.
Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.